Resveratrol as a Novel Anti-Herpes Simplex Virus Nutraceutical Agent: An Overview - PubMed (original) (raw)

Review

Resveratrol as a Novel Anti-Herpes Simplex Virus Nutraceutical Agent: An Overview

Giuseppe Annunziata et al. Viruses. 2018.

Abstract

The herpes simplex virus (HSV) is a common human virus affecting many people worldwide. HSV infections manifest with lesions that occur in different parts of the body, including oral, ocular, nasal, and genital skin and mucosa. In rare cases, HSV infections can be serious and lethal. Several anti-HSV drugs have been developed, but the existence of mutant viruses resistant to these drugs led to the individuation of novel antiviral agents. Plant-derived bioactive compounds, and more specifically polyphenols, have been demonstrated to exert marked anti-HSV activity and, among these, resveratrol (RSV) would be considered a good candidate. The purpose of this manuscript is to review the available literature elucidating the efficacy of RSV against HSV and the main demonstrated mechanisms of action.

Keywords: HSV-1; HSV-2; herpes simplex virus; nutraceutical; polyphenols; resveratrol.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1

Figure 1

Chemical structure of resveratrol (3,5,4′-trihydroxystilbene) isomers.

Figure 2

Figure 2

Chemical structures of resveratrol derivatives. (A) Oxyresveratrol (trans-2,4,3′,5′-tetrahydroxystilbene); (B) oligomeric stilbenoids tested in the study of Chen et al., 2012 [30]: 1, hopeaphenol A; 2, vaticaffinol; 3, davidol A; 4, vaticanol E; 5, neoisohopeaphenol A; 6, pauciflorol C; 7, α-viniferin; 8, pauciflorol B; 9, hemsleyanol D; 10, vaticahainol D.

Figure 3

Figure 3

Main mechanisms of action of resveratrol against HSV infection.

Figure 4

Figure 4

Main mechanisms of action of resveratrol derivatives against HSV infection.

Similar articles

Cited by

References

    1. Suzich J.B., Cliffe A.R. Strength in diversity: Understanding the pathways to herpes simplex virus reactivation. Virology. 2018;522:81–91. doi: 10.1016/j.virol.2018.07.011. - DOI - PMC - PubMed
    1. World Health Organization . WHO Guidelines for the Treatment of Genital Herpes Simplex Virus. World Health Organization; Geneva, Switzerland: 2016. - PubMed
    1. James S.H., Prichard M.N. Current and future therapies for herpes simplex virus infections: Mechanism of action and drug resistance. Curr. Opin. Virol. 2014;8:54–61. doi: 10.1016/j.coviro.2014.06.003. - DOI - PubMed
    1. Vashishtha A.K., Kuchta R.D. Effects of Acyclovir, Foscarnet, and Ribonucleotides on Herpes Simplex Virus-1 DNA Polymerase: Mechanistic Insights and a Novel Mechanism for Preventing Stable Incorporation of Ribonucleotides into DNA. Biochemistry. 2016;55:1168–1177. doi: 10.1021/acs.biochem.6b00065. - DOI - PMC - PubMed
    1. Bostanghadiri N., Pormohammad A., Chirani A.S., Pouriran R., Erfanimanesh S., Hashemi A. Comprehensive review on the antimicrobial potency of the plant polyphenol Resveratrol. Biomed. Pharmacother. 2017;95:1588–1595. doi: 10.1016/j.biopha.2017.09.084. - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources